Treats major depressive disorder (MDD). ANDA 202180, held by Torrent. Trazodone Hydrochloride.
As of Nov 16, 2026, ANDA 202180 (Trazodone Hydrochloride), held by Torrent, was first approved by FDA on Nov 27, 2013, with 5 approved supplements and 0 published complete response letters.
Trazodone hydrochloride tablets, USP are a selective serotonin reuptake inhibitor indicated for the treatment of major depressive disorder (MDD).
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 27, 2013 | Original application | Approved | None posted |
| Trazodone Hydrochloride50MG · tablet;oral | Trazodone Hydrochloride | Rx |
| Trazodone Hydrochloride100MG · tablet;oral | Trazodone Hydrochloride | Rx |
| Trazodone Hydrochloride150MG · tablet;oral | Trazodone Hydrochloride | Rx |
| Trazodone Hydrochloride300MG · tablet;oral | Trazodone Hydrochloride | Rx |
| Jun 24, 2025 | Supplement 14Labeling · Standard review | Approved | None posted |
| Jun 18, 2025 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jun 18, 2025 | Supplement 11Labeling · Standard review | Approved | None posted |
| Jul 18, 2014 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jun 26, 2014 | Supplement 2Labeling · Standard review | Approved | None posted |
| Nov 27, 2013 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters